Cargando…
T405, a New Penem, Exhibits In Vivo Efficacy against M. abscessus and Synergy with β-Lactams Imipenem and Cefditoren
Mycobacteroides abscessus (Mab) is an emerging environmental microbe that causes chronic lung disease in patients with compromised lung function such as cystic fibrosis and bronchiectasis. It is intrinsically resistant to most antibiotics, therefore there are only few antibiotics that can be repurpo...
Autores principales: | Rimal, Binayak, Batchelder, Hunter R., Story-Roller, Elizabeth, Panthi, Chandra M., Tabor, Chavis, Nuermberger, Eric L., Townsend, Craig A., Lamichhane, Gyanu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9211421/ https://www.ncbi.nlm.nih.gov/pubmed/35638855 http://dx.doi.org/10.1128/aac.00536-22 |
Ejemplares similares
-
Development of a penem antibiotic against Mycobacteroides abscessus
por: Batchelder, Hunter R., et al.
Publicado: (2020) -
803. Overcoming β-Lactam Resistance in Mycobacterium abscessus
por: Story-Roller, Elizabeth, et al.
Publicado: (2018) -
Mycobacterium abscessus and β-Lactams: Emerging Insights and Potential Opportunities
por: Story-Roller, Elizabeth, et al.
Publicado: (2018) -
Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates In Vitro and in a Mouse Model of Pulmonary Infection
por: Nicklas, Danielle A., et al.
Publicado: (2022) -
Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease
por: Rimal, Binayak, et al.
Publicado: (2023)